Clinical Gastroenterology and Hepatology

Article	Citations
Information for Authors and Readers	377
Reply	307
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	256
Visualization of Buried Bumper Syndrome With Upper Endoscopy	205
Stratifying the Risk of IPMNs: Don’t Rule Out the EUS Toolkit	191
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	187
Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women	187
Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children	181
Functional Abdominal Pain Disorders and Constipation in Children on Gluten-Free Diet	179
Reply	173
Cover	157
Editorial Board	145
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis	145
Blue Notes	143
Diagnosis of Preclinical Crohn’s Disease: Hurdles, Challenges, and Hopes	141
SARS-CoV-2-Induced Pancreatitis is a Rare but Real Entity	137
Editorial Board	133
Blue Notes	130
Outcomes of Long-term Tumor Necrosis Factor Alpha Inhibitor Therapy Beyond 10 Years in Inflammatory Bowel Disease	128
Reply	125
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility	123
Reply on “Tenofovir is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus-related Hepatocellular Carcinoma”	118
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	116
Table of Contents	115
One Year of Gluten-Free Diet Impacts Gut Function and Microbiome in Celiac Disease	110

Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021	109
Inadequate Efficacy of Biologics for Treating Proximal Ileal Lesions in Crohn’s Disease; A Prospective Multicenter Study	107
Emergency Department Utilization and Outcomes Among Adults With Cirrhosis From 2008 to 2022 in the United States	102
Opening a Can of Worms: A Case of Strongyloidiasis Diagnosed by Colonoscopy	101
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020	100
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	99
Hepatic Artery Pseudoaneurysm After Whipple Procedure	99
Blue Notes	99
Front Cover	98
Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection	97
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion	97
Editorial Board	96
Knot a Typical Clogged Jejunostomy Tube	91
May Computed Tomography Scan as First-Line Investigation Reduce the Overuse of Colonoscopy in Post-Polypectomy Bleeding?	91
Exam 2: Ultra-processed Foods and Risk of Crohn’s Disease and Ulcerative Colitis: A Prospective Cohort Study	86
Cover	84
Association Between Provider Connectedness and Inflammatory Bowel Disease Outcomes	84
Attribution of Colonoscopy Risk Does Not FIT!	84
Endoscopy Training in the Age of Artificial Intelligence: Deep Learning or Artificial Competence?	82
Diffuse Esophageal Adenocarcinoma	80
Diffuse esophageal uptake on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan	80
Issue Highlights	80
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	79
Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases	78
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse	78
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas	78
Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis	77
Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory and Fistulizing Pouch Complications	77
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	76
Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life	76
Health System–Provided Rideshare Is Safe and Addresses Barriers to Colonoscopy Completion	75
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study	75
Cover	74
Leveraging Social Media to Enhance Recruitment Efforts in Fellowship Training Programs	74
Surgery for Strangulated Gastric Volvulus Should Not Be Delayed	74
Effectiveness of Capsule Endoscopy and Double-Balloon Enteroscopy in Suspected Complicated Celiac Disease	73
Table of Contents	72
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network	72
Sex-separated NAFLD/NASH Scores May Improve Predictive Performance	71
Exam 1: Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis	70
Reply	70
Metabolically Healthy Obese MAFLD: Are They Truly Healthy?	70
A Revisit of the Natural History of Nonalcoholic Fatty Liver Disease	68
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	68
Editorial Board	66
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	65
Cover	65
Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B	64
FODMAPs in IBS: Revisiting Restriction	64
An Elusive Pancreatic Mass	63

Reply	62
Contents	62
Reply	61
Reply	61
A Small Esophageal Adenoid Cystic Carcinoma Treated by Endoscopic Submucosal Dissection	61
Editorial Board	60
Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis	60
An Unexpected Case of Right Iliac Fossa Pain: Amyand Hernia	60
Reply	60
Cover	58
Exam 1: Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease	58
Exam 1: What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis	58
A Giant Trichobezoar Diagnosed by Ultrasound, Confirmed by Upper Endoscopy, and Managed by Minimally Invasive Laparoscopic Surgery	57
Exam 2: Factors Associated with Inpatient Endoscopy Delay and Its Impact on Hospital Length-of-Stay and 30-Day Readmission	57
Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis	57
Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy	57
Exam 2: Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis	57
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening	57
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease	57
Outcomes Related to Mucosal Healing in Patients With Crohn's Disease	56
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	56
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!	56
An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction	56
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	56
Lessons Learned From Two Prematurely Terminated, Randomized Trials on Biliary Drainage in Perihilar Cholangiocarcinoma	56
Table of Contents	56
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study	56
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis	55
Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review	54
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	54
Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis	54
Endoscopic Ultrasound–Guided Portosystemic Pressure Gradient Correlates with Clinical Parameters and Liver Histology	54
Decompensation in Patients With Advanced NAFLD: More Questions That Need Answering	53
An Automated Reporting System for Colonoscopy Quality: Lessons in Implementation	53
Survival Times of Patients With Menetrier’s Disease and Risk of Gastric Cancer	53
Reply	53
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	52
An Unusual Encounter in the Rectum	52
Cover	52
Editorial Board	51
The Clue Is in the Stool	51
Elsewhere in the AGA Journals	51
Issue Highlights	51
Blue Notes	50
Risk of Late Postoperative Recurrence of Crohn’s Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers	50
Assessment and Significance of Histologic Activity in Crohn’s Disease	50
Cover	50
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	50
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis	50
Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia	50
Editorial Board	50
Table of Contents	49
Artificial Intelligence Chatbots in Healthcare: Navigating Accuracy, Privacy, and Global Applicability	49
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population	48
Reply	48
GALAD Score for HCC Screening and Surveillance	48
TIPS in Patients With Hepatocellular Carcinoma: Is There an Indication?	48
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in Patients With Alcoholic Hepatitis	48
Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease	48
Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection	47
Efficacy of Mesalamine in Irritable Bowel Syndrome	47
Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease	47
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis	47
Management of Gastrointestinal Side Effects of Immune Checkpoint Inhibitors	47
Cover	47
Near-Complete Disappearance of a Giant Focal Nodular Hyperplasia in the Liver	47
Defining the Long-Term Clinical Course and Need for Repeat Dilation for Patients With Schatzki Rings	46
Endoscopic Diverticular Ridge Myotomy to Treat Acute Colonic Diverticulitis Caused by Impacted Fecalith	46
Elsewhere in the AGA Journals	46
Immunomodulator Withdrawal From Anti-TNF Therapy Needs a Careful Patient Selection	46
Panpancreatic Infiltration and Painless Jaundice in HIV/AIDS	46
Editorial Board	46
Reply	46
Table of Contents	45
Editorial Board	45
Elsewhere in the AGA Journals	44
Assessment of Change in Polymorphs Ascitic Fluid in Spontaneous Bacterial Peritonitis: Need for an “a la Carte” Approach	44
Blue Notes	44
Table of Contents	44
Blue Notes	44

Front Cover	43
Over-the-Scope Clip in the Management of Nonvariceal UGI Bleeding	43
Blue Notes	43
Appendectomy and Future Risk of Microscopic Colitis: A Population-Based Case-Control Study in Sweden	43
Successful Endoscopic Closure of Gastrobronchial Fistula Using Polyglycolic Acid Sheets with Fibrin Glue	43
Table of Contents	43
Hereditary Angioedema: A Rare Cause of Acute Pancreatitis	42
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	42
Reply	42
Editorial Board	42
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease	42
Meet EBE: The Development of an Evidence-Based Endoscopy Simulator	41
Seroprevalence and Determinants of Helicobacter pylori Infection in the Hispanic Community Health Study/Study of Latinos	41
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	41
Reply	41
Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection	41
Asymptomatic Colonic Perforation Caused by PEG Tube Placement	41
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	40
Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death	40
Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome	40
Follow-Up Colonoscopy for Detection of Missed Colorectal Cancer After Diverticulitis	40
Reply	40
Sugar-sweetened Beverages Are Associated With Increased Liver Stiffness and Steatosis Among Apparently Healthy Adults in the United States	40
Editorial Board	39
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	39
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?	39
Killian Jamieson Diverticulum: A Rare Presentation With Food Impaction	39
Blue Notes	39
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	39
Superiority of Self-Expandable Metallic Stents Over Plastic Stents in Treatment of Malignant Distal Biliary Strictures	38
A Rare Case of Esophageal Granular Cell Tumor in Eosinophilic Esophagitis	38
What Gastroenterologists Should Know About COVID-19 Vaccines	38
Modified Crohn’s Disease Exclusion Diet Maintains Remission in Pediatric Crohn’s Disease: Randomized Controlled Trial	38
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	38
A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study	38
Reply	38
Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go	38
Perspectives on the International Consensus for ASUC Clinical Trial Design: Enhancing Clarity and Applicability	37
Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials	37
Testosterone replacement reduces morbidity and mortality for most patients with cirrhosis	37
Atopic Diseases Are Associated With Development of Inflammatory Bowel Diseases in Korea: A Nationwide Population-based Study	37
Patients’ Risk Tolerance for Non-Dietary Therapies in Celiac Disease	37
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine	37
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI	37
Lumen-Apposing Metal Stents in Benign Gastrointestinal Luminal Strictures	37
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	36
Reply	36
Table of Contents	36
Front Cover	36
Reply	36
Underwater Endoscopic Mucosal Resection Vs Conventional Endoscopic Mucosal Resection for Superficial Nonampullary Duodenal Epithelial Tumors in the Western Setting	36
Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort Study	36
Performance and Predictors of Migration of Partially and Fully Covered Esophageal Self-Expanding Metal Stents for Malignant Dysphagia	36
Biliary Neuroendocrine Tumor	36
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage	36
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease	35
Automated Neutrophil Quantification and Histological Score Estimation in Ulcerative Colitis	35
Elsewhere in the AGA Journals	35
Correction	35
Endoscopic Findings of a Splenic Vein Stent Eroding Into a Pancreatic Fluid Collection	35
Clonorchis sinensis Infection Detected by Capsule Endoscopy: A Rare Cause of Body Weight Loss	35
Editorial Board	35
AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review	35
Validation of a National Pathology Database for Colonoscopy Quality Reporting and Assurance	35
Not So Nutty for Coconut Water	35
Management of Adults With Esophageal Atresia	35
Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada	34
Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study	34
The Placebo Response in Randomized Trials in Nonalcoholic Steatohepatitis Simply Explained	34
Table of Contents	34
Blue Notes	34
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy	34
Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation	34
Impostor Phenomenon and Microaggressions in Gastroenterology: Exposing the Tip of the Iceberg	34
Net Remission Rates with Biologic Treatment in Crohn’s Disease: A Reappraisal of the Clinical Trial Data	34
Editorial Board	33
Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia	33
A Trial of Ornithine Phenylacetate and the Arc of Ammonia’s History in the Management of Overt Hepatic Encephalopathy	33
Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial	33
Interleukin-1 Inhibition in Alcohol-associated Hepatitis: Are We Hitting the Right Target?	33
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care	33
Endoscopic sleeve gastroplasty plus lifestyle intervention in patients with MASH: a multicentre, sham-controlled, randomized trial.	33
Reply	33
Table of Contents	33
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	33
Daily or Twice Daily Treatment with Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	33
Activation of the Innate Immune System in Children With Irritable Bowel Syndrome Evidenced by Increased Fecal Human β-Defensin-2	33
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent	33
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	32
High Prevalence of Osteopathy in Chronic Pancreatitis: A Cross-sectional Analysis From the PROCEED Study	32
Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium	32
Histology, Size, and Number of Advanced Polyps are Associated With Guideline-Discordant Surveillance Recommendations	32
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults	32
Frequency of Bowel Movements and Risk of Diverticulitis	32
Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists	32